Salspera is a clinical-stage biotechnology company committed to developing novel therapies for solid tumor cancers. The company has a platform of microbial immunotherapies that have the potential to address a range of solid tumor cancers where unmet medical need is high. We believe microbial immunotherapies could be used to create a new category of medicines with significant potential to improve the lives of patients.
Company Details
- Employees
- 2
- Address
- Cambridge, Ma, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- salspera.com
- HQ
- Cambridge, MA
Salspera Questions
Salspera's website is salspera.com
Salspera's LinkedIn profile is https://www.linkedin.com/company/salspera-llc
Salspera has
2 employees.
View email and phone details for 2
employees at Salspera.
Salspera's industry is
Biotechnology Research
Salspera's top competitors are
Transpacific Venture Partners,
Md Biosciences Neuro,
Actym Therapeutics, Inc.,
Syngene International Limited,
Nuclera,
Revolution Medicines,
Md Bioproducts,
Ucsf Health,
Infinity Genomics,
Regeneron.
Salspera's categories are Biotechnology Research
